Literature DB >> 30547319

Interferon-α-induced retinopathy in chronic hepatitis C treatment: summary, considerations, and recommendations.

Zubir S Rentiya1, Matthew Wells2, Junun Bae1,2, Kuan-Jen Chen3, An-Ning Chao3, Nicholas Turgeon2, Syed M Shah4, Mostafa Hanout5.   

Abstract

Interferons are cytokines that regulate the host's response to viral infection, particularly in the setting of the immunologic response to the hepatitis C virus (HCV). While the virus has the ability to evade the host's innate and specific immunity, exogenous interferon-α with combined ribavirin, treatments have been found to achieve a significant sustained viral response in subgroups of patients with chronic HCV. One of the major side effects of interferon-α is an ocular retinopathy characterized by flame-shaped hemorrhages and cotton wool spots visualized on funduscopic examination. There have been documented cases of more severe side effects including optic nerve and retinal artery damage; however, these instances are the minority. We sought to investigate the literature surrounding interferon-induced retinopathy, clinically correlate our findings with two recent cases, and provide recommendations for practitioners who continue to manage chronic HCV patients using interferon-α with combined ribavirin treatments.

Entities:  

Keywords:  Fundoscopic imaging; Hepatitis C; Interferon; Macular edema; Neuropathy; Ocular toxicity; Optical coherence tomography; Retinopathy

Mesh:

Substances:

Year:  2018        PMID: 30547319     DOI: 10.1007/s00417-018-04209-7

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  2 in total

1.  Unilateral retinopathy post perilesional interferon α2b injections for ocular surface squamous cell carcinoma.

Authors:  Shiv Dalla; Mary Champion; Radwan Ajlan; John E Sutphin; Jason A Sokol
Journal:  Am J Ophthalmol Case Rep       Date:  2021-08-27

Review 2.  Ocular side effects of antirheumatic medications: a qualitative review.

Authors:  Clara M Castillejo Becerra; Yue Ding; Beatrice Kenol; Andrew Hendershot; Alexa Simon Meara
Journal:  BMJ Open Ophthalmol       Date:  2020-01-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.